Title:
ＦＧＦ２１突然変異体及びその使用
Document Type and Number:
Japanese Patent JP7191076
Kind Code:
B2
Abstract:
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
Inventors:
Edward Zyon Berowski
Muriel Marie Ellison
Agnes Eva Hamburger
Randy Isla Hecht
Yue-Shion Lee
Mark Leo Michaels
Ji Young Hoon Seung
Gene Shiyu
Muriel Marie Ellison
Agnes Eva Hamburger
Randy Isla Hecht
Yue-Shion Lee
Mark Leo Michaels
Ji Young Hoon Seung
Gene Shiyu
Application Number:
JP2020204106A
Publication Date:
December 16, 2022
Filing Date:
December 09, 2020
Export Citation:
Assignee:
Amjien Incorporated
International Classes:
C12N15/12; A61K38/18; A61K47/60; A61K47/64; A61K47/65; A61K47/68; A61P3/00; A61P3/04; A61P3/10; A61P43/00; C07K14/50; C07K19/00; C12N1/15; C12N1/19; C12N5/10; C12N15/62; C12N15/63
Domestic Patent References:
| JP2008506635A | ||||
| JP2007535306A | ||||
| JP2007531715A |
Foreign References:
| WO2010042747A1 | ||||
| WO2006065582A1 |
Attorney, Agent or Firm:
Kawaguchi International Patent Office